Viatris Inc. (VTRS)
Last updated: 2026-10-21 15:34:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Viatris Inc. (VTRS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $18.64, with a market capitalization of $20.97B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.92 to $18.75. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$20.97B | |
$18.64 | |
$18.86 | |
$6.85 | |
$18.65 | |
1.19M | |
9.32M | |
-- | |
$18.75 | |
$9.92 | |
-- | |
-- |
Viatris Inc. (VTRS) Stock Price Today
Viatris Inc. (VTRS) is currently trading at $18.64 as of 2026-10-21 15:18:19, down 0.08% ($0.01) from the previous close of $18.65
During today's regular trading session, VTRS has traded between $6.85 and $18.86, with a trading volume of 1.19M shares. The current price is near the upper end of today's range.
Viatris Inc. (VTRS) 7-Day Stock Price Change
Over the past seven days, Viatris Inc. (VTRS) moved from $17.54 to $18.64, representing a gain of 6.24% ($1.10).
The stock traded between $17.21 and $18.75 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 9.63 million shares, up versus the previous seven-day period, indicating higher trading activity.
VTRS 52-Week Price Position
Position in Range: 98.7%
VTRS is currently trading at $18.64, placing it 98.7% of the way from its 52-week low of $9.92 to its 52-week high of $18.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Viatris Inc. (VTRS)?
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.
Viatris Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 30000 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Viatris Inc. (VTRS) Stock on MEXC
Eligible investors can buy real shares of Viatris Inc. (VTRS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Viatris Inc. (VTRS) stock price today?
2.Is VTRS stock going up or down today?
3.What is VTRS pre-market price?
4.What is VTRS after-hours price?
5.Is VTRS stock trading now?
6.Where does VTRS sit relative to its 52-week high and low?
7.What sector is Viatris Inc. in?
8.What is Viatris Inc.'s market capitalization and where is it listed?
9.How is VTRS valued in terms of P/E ratio and EPS?
10.Does Viatris Inc. pay a dividend?
Explore More US Stocks
Search Stocks
VTRS Stock Calculator
Estimate the value between VTRS shares and USD.
VTRS Shares to USD
1.00 VTRS shares = 18.635 USD
Calculations are estimates based on the latest available price and are for reference only.


